ANTITUSSIVE

Pre-Launch

diphenhydramine hydrochloride

Design Pharmaceuticals

ANDAORALSYRUP

Lifecycle

Pre-Launch

Clinical Trials

Data completeness

3/8 — Basic

ANTITUSSIVE (diphenhydramine hydrochloride) by Design Pharmaceuticals is clinical pharmacology diphenhydramine hydrochloride is an antihistamine with anticholinergic (drying) and sedative side effects. Approved for common cold symptoms: cough due to minor throat & bronchial irritation helps loosen phlegm (mucus), thin bronchial secretions to: drain bronchial tubes make coughs more productive.

Drug data last refreshed 1mo ago

Mechanism of Action

CLINICAL PHARMACOLOGY Diphenhydramine hydrochloride is an antihistamine with anticholinergic (drying) and sedative side effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells. Diphenhydramine hydrochloride in the injectable form has a rapid onset of…

Indications (2)

common cold symptoms: cough due to minor throat & bronchial irritation helps loosen phlegm (mucus)

Worked on ANTITUSSIVE at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Clinical Trials (5)

NCT03424135Phase 1Completed

A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects Under Fed Conditions

Started Mar 2018

60 enrolled

Clinical Pharmacology

NCT03396250Phase 1Completed

A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects

Started Feb 2018

36 enrolled

Pain

NCT01597349Phase 2Completed

Antitussive Effects of FP01 Lozenges in Subjects With Cough Due to Upper Respiratory Tract Infection

Started May 2012

208 enrolled

Acute Cough

NCT01666678Phase 1Completed

Compare Pharmacokinetic (PK) Profiles of Naproxen Sodium, Diphenhydramine Hydrochloride, and Naproxen Sodium and Diphenhydramine Hydrochloride Combination

Started Jan 2012

32 enrolled

Therapeutic Equivalence

NCT00662337Phase 1Completed

Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

Started Oct 2006

36 enrolled

Nasal Congestion